News & Updates

As the clinical research landscape evolves, digital transformation has emerged as a critical enabler for improving trial efficiency, data quality, and regulatory alignment.

The European Medicines Agency (EMA) is the central regulatory body overseeing the evaluation, supervision, and monitoring of medicinal products within the EU.

The pharmaceutical industry is shifting toward Risk-Based Quality Management (RBQM) to enhance trial efficiency and data integrity.

In the pharmaceutical industry, ensuring the ethical and scientifically rigorous conduct of clinical trials is essential to patient safety, data integrity, and medicine development success.

In the highly regulated pharmaceutical industry, ensuring compliance with evolving guidelines is critical to maintaining product quality, patient safety, and operational efficiency.

To improve efficiency, reduce costs, and bring high-quality therapies to patients faster, Vilintra is implementing the ICH M13 Guidelines.

The pharmaceutical industry continues to evolve rapidly, driven by increasing complexity in clinical trials and stringent regulatory demands.

GAMP® 5 (Good Automated Manufacturing Practice) is a globally recognized guideline for ensuring the quality, reliability, and compliance of automated systems in regulated industries like pharmaceuticals.